Search

Your search keyword '"Simon Tiberi"' showing total 237 results

Search Constraints

Start Over You searched for: Author "Simon Tiberi" Remove constraint Author: "Simon Tiberi"
237 results on '"Simon Tiberi"'

Search Results

1. Expert views on screening for tuberculosis infection in patients commencing treatment with a biologic agent

2. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study

3. Update of drug-resistant tuberculosis treatment guidelines: A turning point

4. Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study

5. Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

6. World TB Day 2022: Revamping and Reshaping Global TB Control Programs by Advancing Lessons learnt from the COVID-19 pandemic

7. Drug resistant TB – latest developments in epidemiology, diagnostics and management

9. Global variations in the burden of SARS-CoV-2 infection and its outcomes in pregnant women by geographical region and country’s income status: a meta-analysis

11. Clinical management of community-acquired meningitis in adults in the UK and Ireland in 2017: a retrospective cohort study on behalf of the National Infection Trainees Collaborative for Audit and Research (NITCAR)

12. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

13. Using ISARIC 4C mortality score to predict dynamic changes in mortality risk in COVID-19 patients during hospital admission

14. Case studies to illustrate good practice in the management of non-tuberculous mycobacterial pulmonary disease

15. A case of Clival Tuberculosis and associated meningitis

16. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

17. Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic

18. World Tuberculosis Day 2021 Theme — ‘The Clock is Ticking’ — and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic

19. Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study

20. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

21. Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol

22. The limitations of the Cepheid GeneXpert® Mtb/Rif assay for the diagnosis and management of polyresistant pulmonary tuberculosis

23. Post tuberculosis treatment infectious complications

24. Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients

25. Commemorating World TB Day 2020: 'IT’S TIME' — It’s time to End the Global TB Epidemic

26. Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use?

27. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

28. Tools to implement the World Health Organization End TB Strategy: Addressing common challenges in high and low endemic countries

29. A postgraduate qualification in tuberculosis—Message in a bottle

30. Non-tuberculous mycobacterial infections—A neglected and emerging problem

31. Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network

32. Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

33. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

34. Classifying new anti-tuberculosis drugs: rationale and future perspectives

35. Shigellosis and toxic megacolon secondary to Shigella flexneri serotype 3a: The challenges of laboratory diagnosis

36. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 — 'Wanted: Leaders for a TB-Free World. You can make history. End TB'

37. Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation

39. Challenging MDR-TB clinical problems – The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs

40. Post-Tuberculosis (TB) Treatment: The Role of Surgery and Rehabilitation

41. Tuberculosis elimination: where are we now?

42. Multidrug-Resistant Tuberculosis in Europe, 2010–2011

45. Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

46. Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review

47. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

48. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY)

49. Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools

50. Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs

Catalog

Books, media, physical & digital resources